El interés en corto de Truist Finl da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Truist Finl. Los datos de interés en corto se actualizan cada dos semanas.

Truist Finl (NYSE:TFC) Bolsa, Informe de interés en corto

Truist Finl

Based in Charlotte, North Carolina, Truist is the combination of BB&T and SunTrust. Truist is a regional bank with a presence primarily in the Southeastern United States. In addition to commercial banking, retail banking, and investment banking operations, the company operates several nonbank segments.

<figure class="wp-block-image size-large"><img decoding="async" src="https://thearorareport.com/wp-content/uploads/2025/07/2025-07-06_08h02_40-Edited.jpg" alt="" /></figure>
To gain an edge, this is what you need to know today.
<h4 class="wp-block-heading">America Party</h4>
Please <a href="https://thearorareport.com/stock-market-chart-analysis-stock-market-m2-money-supply-mc-07062025">click here</a> for an enlarged chart of M2 money supply (M2).
Note the following:
<ul class="wp-block-list">
<li>The chart shows M2 money supply rose sharply during the pandemic.&nbsp; The M2 money supply represents the total amount of money in circulation that includes M1 (cash and checking accounts) plus savings accounts, small deposits, and retail money market funds.</li>
<li>The chart shows that when the government free money train stopped, M2 money supply dipped.&nbsp;</li>
<li>The chart shows that M2 money supply has been rising since last year.</li>
<li>The chart shows that M2 money supply has hit a new record.</li>
<li>As M2 money supply hits a new record, part of the liquidity created by more money circulation is going into the stock market causing the stock market to rise.&nbsp;&nbsp;</li>
<li>The ‘One Big Beautiful Bill Act' (OBBBA) is projected to increase the Federal Deficit by $2.8T over the next decade and will likely fuel money supply increase.</li>
<li>In our analysis, the realistic cost of OBBBA is $5T, and not $2.8T, as politicians are unlikely to end Trump's temporary tax cuts.</li>
<li>For prudent investors, mounting debt is a concern as it is not sustainable in the long term.&nbsp; In contrast, for the momo crowd, mounting debt is a reason to buy stocks as some of the borrowed money flows into the stock market.</li>
<li>There is some selling in the stock market in the early trade for three reasons: 
<ul class="wp-block-list">
<li>Musk is forming the America Party to challenge the excessive spending and borrowing.&nbsp;&nbsp;</li>
<li>Trump is threatening BRICS with 10% tariffs for Anti-American policies.&nbsp; BRICS originally included Brazil, Russia, India, China, and South Africa, and recently added Egypt, The United Arab Emirates, Ethiopia, Indonesia, and Iran.&nbsp; BRICS over the weekend, expressed ‘serious concerns about the rise of unilateral tarrif and non-tarrif measures.'</li>
<li>There is also concern about the approaching July 9th tariff deadline.</li>
</ul>
</li>
<li>In our analysis, the momo crowd's concern about the America Party is valid. If the America Party gains traction, it will be a negative for the present policy of reckless borrowing and spending.  It will be negative in the short term to medium term for the stock market but positive for the stock market in the very long term.  It is worth a reminder that the momo crowd is always exclusively focused on the short term and doesn't care about the long term.</li>
<li>Tesla Inc (TSLA) stock is down about 6% in the early trade on Musk forming the America Party.  There are twin concerns here: 
<ul class="wp-block-list">
<li>Musk will be distracted.</li>
<li>President Trump may retaliate against TSLA.</li>
</ul>
</li>
<li>The momo crowd is aggressively buying the shallow dip in the stock market.</li>
</ul>
<h4 class="wp-block-heading">Magnificent Seven Money Flows</h4>
Money flows are positive in Amazon.com, Inc. (AMZN) and Microsoft Corp (MSFT).
Money flows are negative in NVIDIA Corp (NVDA), Alphabet Inc Class C (GOOG), Meta Platforms Inc (META), TSLA, and Apple Inc (AAPL).
Money flows are negative in SPDR S&amp;P 500 ETF Trust (SPY) and Invesco QQQ Trust Series 1 (QQQ).
<h4 class="wp-block-heading">Momo Crowd And Smart Money In Stocks</h4>
Investors can gain an edge by knowing money flows in SPY and QQQ.  Investors can get a bigger edge by knowing when smart money is buying stocks, gold, and oil.  The most popular ETF for gold is SPDR Gold Trust (GLD).  The most popular ETF for silver is iShares Silver Trust (SLV).  The most popular ETF for oil is United States Oil ETF (USO).
<h4 class="wp-block-heading">Oil</h4>
In a strange twist of events, OPEC+ plans to increase oil supply by more than expectations but Saudi Arabia is planning to increase oil prices next month.&nbsp; The reason Saudi Arabia is able to increase prices even when supply is being increased is that summer is a peak demand season in the Northern Hemisphere.
<h4 class="wp-block-heading">Bitcoin</h4>
Bitcoin is seeing mild buying.
<h4 class="wp-block-heading">Arora Protection Band And What To Do Now</h4>
It is important for investors to look ahead and not in the rearview mirror.  Our proprietary Protection Band puts all of the data, all of the indicators, all of the news, all of the crosscurrents, all of the models, and all of the analysis in an analytical framework that is easily actionable by investors. 
Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider a protection band consisting of cash or Treasury bills or short-term tactical trades as well as short to medium term hedges and short term hedges. This is a good way to protect yourself and participate in the upside at the same time.
You can determine your protection bands by adding cash to hedges.&nbsp; The high band of the protection is appropriate for those who are older or conservative. The low band of the protection is appropriate for those who are younger or aggressive.&nbsp; If you do not hedge, the total cash level should be more than stated above but significantly less than cash plus hedges.
A protection band of 0% would be very bullish and would indicate full investment with 0% in cash.&nbsp; A protection band of 100% would be very bearish and would indicate a need for aggressive protection with cash and hedges or aggressive short selling.
It is worth reminding that you cannot take advantage of new upcoming opportunities if you are not holding enough cash.&nbsp; When adjusting hedge levels, consider adjusting partial stop quantities for stock positions (non ETF); consider using wider stops on remaining quantities and also allowing more room for high beta stocks.&nbsp; High beta stocks are the ones that move more than the market.
<h4 class="wp-block-heading">Traditional 60/40 Portfolio</h4>
Probability based risk reward adjusted for inflation does not favor long duration strategic bond allocation at this time.
Those who want to stick to traditional 60% allocation to stocks and 40% to bonds may consider focusing on only high quality bonds and bonds of five year duration or less.&nbsp; Those willing to bring sophistication to their investing may consider using bond ETFs as tactical positions and not strategic positions at this time.
The Arora Report is known for its accurate calls. The Arora Report correctly called the big artificial intelligence rally before anyone else, the new bull market of 2023, the bear market of 2022, new stock market highs right after the virus low in 2020, the virus drop in 2020, the DJIA rally to 30,000 when it was trading at 16,000, the start of a mega bull market in 2009, and the financial crash of 2008. Please click here to sign up for a free forever <a href="https://thearorareport.com/generate-wealth-newsletter-benzinga">Generate Wealth Newsletter</a>.

Market Summary

Broad U.S. Equity ETFs

Opinion

Markets

Trading Ideas

Money Supply Hits Record; Elon Musk's 'America Party' Stirs Debate; Trump Targets BRICS

WIIM

ORKA

Oruka Therapeutics shares are trading higher on possible continued strength after the company introduced its new COO on Thursday after hours.

Nearly six months into President Donald Trump's second term, the market has picked its winners—and it's not on ESG, the strategy built around environmental,<a href="https://www.benzinga.com/markets/esg"> social and governance principles.</a>
As deregulation gains steam and culture wars escalate, a group of so-called &#8220;sin stocks&#8221; tied to guns, booze, tobacco, and gambling is sharply beating clean investing strategies.
<h3 class="wp-block-heading">Sin Stocks Are Smoking ESG—and Trump Might Be The Reason</h3>
Since Trump's inauguration on Jan. 20, 2025, the USA Mutuals Vice Fund (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VICEX#NASDAQ">VICEX</a>) — a portfolio built around industries typically shunned by ethical investors — has jumped 16.4%. By contrast:
<ul class="wp-block-list">
<li>The Vanguard ESG U.S. Stock ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESGV#NYSE">ESGV</a>) is up just 3.5%.</li>
<li>The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) gained 4.2%.</li>
<li>The Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) rose 6%. </li>
</ul>
This shift reflects a broader investor reallocation toward industries that benefit from Trump's deregulatory, America-first agenda—and away from sectors screened for ESG compliance.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="529" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07105031/image-66-1024x529.png" alt="" class="wp-image-975026" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07105031/image-66-1024x529.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07105031/image-66-300x155.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07105031/image-66-768x397.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07105031/image-66-1536x794.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07105031/image-66-2048x1059.png 2048w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h2 class="wp-block-heading">What's Driving Sin Stocks Higher?</h2>
The USA Mutuals Vice Fund, launched in 2002, invests at least 80% of its assets in companies tied to alcohol, tobacco, gambling, and defense.
It concentrates a minimum of 25% in these four "vice industries," which the fund defines as sectors often subject to social disapproval or regulatory risk. 
No single industry makes up more than 80% of the portfolio. The fund also maintains global exposure, investing at least 40% of assets in non-U.S. companies across a minimum of three countries.
 Its top holdings as of March 31, 2025 have delivered eye-catching returns in 2025:
<ul class="wp-block-list">
<li>BAE Systems plc (OTCPK: BAESY): +79.3%</li>
<li>Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>): +51.8%</li>
<li>British American Tobacco p.l.c. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTI#NYSE">BTI</a>): +46.9%</li>
<li>Anheuser-Busch InBev SA/NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUD#NYSE">BUD</a>): +38.8%</li>
<li>RTX Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>): +28.0%</li>
<li>Alibaba Group Holding Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>): +28.5%</li>
<li>Heineken N.V. (OTCPK: HEINY): +25.9%</li>
<li>Northrop Grumman Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>): +9.4%</li>
<li>Diageo plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEO#NYSE">DEO</a>): -17.1% (the lone laggard). </li>
</ul>
In particular, a portfolio of defense contractors—tracked by the iShares U.S. Aerospace &amp; Defense ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITA#NYSE">ITA</a>)—has surged 25% year-to-date, fueled by rising geopolitical tensions and further escalated by the recent Israel–Iran war.
&#8220;The Vice Fund remains committed to its core belief that certain stocks are undervalued because certain factions of society deem them morally questionable,&#8221; said portfolio manager Paul Strehle in the fund's latest quarterly report.
&#8220;Our core holdings remain military defense, casino, alcohol, and tobacco stocks because they typically have an inelastic customer base that is unlikely to be swayed by whether the product price rises or falls,&#8221; he added. 
<h2 class="wp-block-heading">ESG Stocks Struggle Despite Big Tech Exposure</h2>
Despite the Vanguard ESG U.S. Stock ETF including several of the market's strongest tech names, it hasn't kept up with vice stocks. 
Top 10 ESGV Holdings and 2025 YTD Returns:
<ul class="wp-block-list">
<li>Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>): +18.1%</li>
<li>Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>): +18.6%</li>
<li>Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>): -15.1%</li>
<li>Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>): +2.0%</li>
<li>Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>): +24.3%</li>
<li>Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>): +20.0%</li>
<li>Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>): -6.1%</li>
<li>Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>): -27.4%</li>
<li>Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>): -6.1%</li>
<li>JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>): +24.8%</li>
</ul>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46271577/trumps-big-beautiful-bill-slashes-solar-incentives-cathie-woods-ark-says-nuclear-may-now-be-cheapest-option-oklo-smr-ltbr-and-other-stocks-in-focus">Trump&#8217;s Big Beautiful Bill Slashes Solar Incentives — Cathie Wood&#8217;s Ark Says Nuclear May Now Be Cheapest Option: OKLO, SMR, LTBR And Other Stocks In Focus </a></li>
</ul>
Photo: Shutterstock

Equities

Government

Large Cap

Regulations

Sector ETFs

Specialty ETFs

AAPL

AMZN

AVGO

BABA

BAESY

ESGV

GOOGL

HEINY

iShares Dow Jones US Aerospace & Defense Index Fund

MSFT

NVDA

TSLA

VICEX

Guns, Booze, And Gambling Stocks Are Crushing ESG In Trump's America

POET

POET Technologies shares are trading lower after the company announced a $25 million public offering.

DEFT

DeFi Technologies shares are trading lower after the company provided FY25 revenue guidance.

AMBR

Amber International shares are trading higher after the company announced it filed for a $500 mixed shelf offering.

CoreWeave Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) and Core Scientific Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>) shares are moving lower Monday after the companies announced <a href="https://www.benzinga.com/pressreleases/25/07/b46272286/coreweave-to-acquire-core-scientific">a merger deal</a>.
What Happened: CoreWeave and Core Scientific entered into a definitive agreement in which CoreWeave will acquire Core Scientific in an all-stock deal. 
Under terms of the agreement, Core Scientific shareholders will receive 0.1235 newly issued shares of CoreWeave common stock for each Core Scientific share held. 
The deal is expected to help CoreWeave verticalize its data center footprint to &#8220;future-proof revenue growth&#8221; and amplify profitability.&nbsp;Following the transaction, CoreWeave will own approximately 1.3 GW of power across Core Scientific&#8217;s footprint with another 1 GW plus of potential power available for expansion.
&#8220;Verticalizing the ownership of Core Scientific&#8217;s high-performance data center infrastructure enables CoreWeave to significantly enhance operating efficiency and de-risk our future expansion, solidifying our growth trajectory,&#8221; said Michael Intrator, co-founder, chairman and CEO of CoreWeave.
&#8220;Owning this foundational layer of our platform will enhance our performance and expertise as we continue helping customers unleash AI&#8217;s full potential.&#8221;
The deal implies a total equity value of $9 billion, which represents a value of $20.40 per share. The acquisition is expected to close in the fourth quarter.
Core Scientific shares had been up significantly in recent weeks following reports that the company was in talks with CoreWeave about a potential deal. Even with Monday&#8217;s pullback, Core Scientific shares are still up about 26% over the past month.
Price Action: At the time of publication, <a href="http://benzinga.com/quote/CRWV">CoreWeave shares</a> were down 3.50% at $159.10 and <a href="http://benzinga.com/quote/CORZ">Core Scientific shares</a> were down 16.8% at $14.99, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46269806/pony-ai-to-deploy-robotaxis-in-dubai-trials-begin-late-2025">Pony.ai To Deploy Robotaxis In Dubai, Trials Begin Late 2025</a></li>
<li><a href="https://www.benzinga.com/markets/tech/25/07/46270569/oracle-offers-deep-discounts-to-us-government-on-ai-cloud-and-database-tools-report">Oracle Offers Deep Discounts To US Government On AI, Cloud And Database Tools: Report</a></li>
</ul>
Photo: VL-PhotoPro/Shutterstock.com

News

Movers

Core Scientific, Inc. - Class A Common Stock

CORZ

CRWV

CoreWeave, Core Scientific Shares Move Lower On $9 Billion All-Stock Deal

Progressive shares are trading lower after Morgan Stanley downgraded the stock from Overweight to Equal-Weight and cut its price target from $330 to $290.

Rumors

IPOs

MAMK

MaxsMaking IPO Indicating $4.00/Share On 86K Shares

Mustang Bio Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIO#NASDAQ">MBIO</a>) shares are trading sharply higher Monday afternoon. The company earlier saw a positive development as the FDA granted Orphan Drug Designation to its cell therapy candidate, MB-101. Here&#8217;s what investors <a href="https://www.benzinga.com/quote/MBIO/news">need to know</a>.
What To Know: This designation is for the treatment of aggressive brain cancers, including recurrent diffuse and anaplastic astrocytoma and glioblastoma.
Per Mustang Bio, the designation provides <a href="https://www.benzinga.com/pressreleases/25/07/g46272398/mustang-bio-granted-orphan-drug-designation-by-u-s-fda-for-mb-101-il13ra2-targeted-car-t-cells-to-">significant incentives</a>, including potential tax credits, user fee waivers and seven years of market exclusivity upon approval. This status is granted to therapies for rare diseases affecting fewer than 200,000 people in the United States.
Manuel Litchman, M.D., President and CEO of Mustang, expressed enthusiasm, stating the designation is a &#8220;strong validation for our science.&#8221; He highlighted the company&#8217;s strategy to combine MB-101, a CAR T-cell therapy, with MB-108, an oncolytic virus. This combination aims to enhance the tumor-fighting capabilities of MB-101.
According to the company, preclinical data has shown promise for this dual approach. Notably, two patients with &#8220;hot&#8221; tumors, indicating a pre-existing immune response, achieved complete and lasting remissions when treated with MB-101 alone.
Phase 1 clinical trials for both therapies are ongoing. However, Mustang Bio emphasized that further development of this promising brain cancer program is contingent on securing additional funding or a strategic partnership.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, MBIO shares are trading higher by 191.6% to $3.47 Monday afternoon. The stock has a 52-week high of $25.00 and a 52-week low of $0.89.
Read Also: <a href="https://www.benzinga.com/news/health-care/25/07/46273670/why-is-cogent-biosciences-stock-trading-higher-on-monday-2">Why Is Cogent Biosciences Stock Trading Higher On Monday?</a>
<h2 class="wp-block-heading">How To Buy MBIO Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Mustang Bio&#8217;s case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
Image: Shutterstock

MBIO

Mustang Bio (MBIO) Stock Explodes 260% After FDA Grants Key Cancer Drug Designation

CHYM

Chime Financial shares are trading higher after several firms initiated coverage on the stock with bullish ratings, including Outperform, Overweight, and Buy ratings.

SLM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLM#NASDAQ">SLM</a>) has outperformed the market over the past 5 years by 23.59% on an annualized basis producing an average annual return of 37.92%. Currently, SLM has a market capitalization of $7.11 billion. 
Buying $1000 In SLM: If an investor had bought $1000 of SLM stock 5 years ago, it would be worth $5,180.58 today based on a price of $33.87 for SLM at the time of writing.
<h3>SLM's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751906711_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In SLM 5 Years Ago Would Be Worth Today

Shares of Robinhood Markets Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) are trading flat on Monday. Following a turbulent week of trading last week, the stock rallied to a new all-time high. Here&#8217;s what investors <a href="https://www.benzinga.com/quote/HOOD/news">need to know</a>.
What To Know: Last week, investor enthusiasm was <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46225339/robinhood-stock-surges-to-all-time-high-on-aggressive-crypto-expansion-whats-going-on">significantly fueled</a> by a series of major announcements centered on an aggressive expansion into the cryptocurrency market. The company revealed its planned acquisition of the Bitstamp crypto exchange and the introduction of commission-free tokenized U.S. equities and perpetual futures for its European customers. 
This strategic push into digital assets aims to establish &#8220;crypto as the backbone of the global financial system,&#8221; according to CEO Vlad Tenev.
This ambitious roadmap for international growth and innovation prompted KeyBanc Capital Markets to <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46248233/robinhood-stock-pulls-back-from-all-time-highs-whats-going-on">nearly double</a> its price target on Robinhood to $110, maintaining an Overweight rating. 
The firm cited Robinhood's &#8220;first-rate innovation&#8221; and &#8220;TAM expansion&#8221; as key drivers for the upgraded outlook, projecting revenues of $3.77 billion and a GAAP EPS of $1.31 for 2025.
However, the week was not without its setbacks. The stock experienced a brief retreat after it <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46236303/datadog-stock-surges-on-sp-500-inclusion">was not included</a> in the latest S&amp;P 500 index reconstitution, a development many investors had anticipated.
Additionally, following public warnings from OpenAI disavowing any partnership over Robinhood&#8217;s new &#8220;stock tokens,&#8221; CNBC <a href="https://www.cnbc.com/2025/07/07/robinhood-stock-tokens-face-scrutiny-in-the-eu-after-openai-warning.html">earlier on Monday</a> reported Lithuania&#8217;s central bank is now seeking clarification from the company. 
The regulator, which is Robinhood&#8217;s lead authority in the EU, is assessing the legality of the financial instruments and whether the communication to investors is fair and not misleading.
Analyst Ratings: Wall Street has shown a flurry of recent activity around Robinhood, with sentiment leaning positive. Last week, Mizuho maintained its Outperform rating while raising its price target to $99. This follows similar bullish moves in late May from Goldman Sachs and Compass Point, both of which reiterated Buy ratings with increased targets.
However, conviction is not universal. In early May, Redburn Atlantic took a more cautious stance, downgrading the stock to Sell with a price target of $40 to $48.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, HOOD shares are trading marginally lower by 1.19% to $93.28 during Monday&#8217;s session. The stock has a 52-week high of $100.88 and a 52-week low of $13.98.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46250633/whats-going-on-with-webull-stock-2">What&#8217;s Going On With Webull Stock?</a>
<h2 class="wp-block-heading">How To Buy HOOD Stock</h2>
By now you're likely curious about how to participate in the market for Robinhood Markets &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Robinhood Markets, which is trading at $94.44 as of publishing time, $100 would buy you 1.06 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
Image: Shutterstock

HOOD

What's Going On With Robinhood Markets (HOOD) Stock?

Dow shares are trading lower after the company announced it will shut down three European plants, which may result in up to $790 million worth of asset write-downs.

United Microelectronics shares are trading lower following its reported June 2025 sales growth numbers.

Trading Halt: Halt status updated at 12:40:00 PM ET: Quotation Resumption: IPO Security - Released for Quotation

The year 2025 will go down in history for tech giant Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), but it won't be an iPhone or a new product launch. The year will mark the company's biggest box office movie of all time with "F1."
While the film is breaking box office records, it might not move the needle for Apple stock.
What Happened: Action movie "F1," which stars Brad Pitt, ranked second at the domestic box office during the Fourth of July holiday weekend with $26.1 million, <a href="https://www.benzinga.com/news/entertainment/25/07/46277528/dinosaurs-dominate-box-office-jurassic-world-rebirth-comcast">trailing only "Jurassic World Rebirth."</a>
The film has grossed $109.5 million domestically and $293.6 million worldwide after 10 days in theaters.
With the latest weekend box office total, "F1" is now the highest-grossing Apple theatrical film of all time, surpassing the $221 million total from "Napoleon," as reported by <a href="https://variety.com/2025/film/box-office/f1-movie-apple-highest-grossing-film-napoleon-1236448149/">Variety</a>.
With a strong sophomore weekend showing, "F1" could not only be the highest grossing Apple film of all time, but could surpass the theatrical totals of all Apple's previous films, including "Killers of the Flower Moon," which grossed $158 million and "Argylle," which grossed $96 million.
Many movie companies would likely see their stock prices rise if they were breaking all-time company or box office records. In the case of Apple, though, the film's success hasn't moved the Apple stock price much to date.
Apple&#8217;s previous big-budget films, "Napoleon" and "Killers of the Flower Moon,&#8221; had budgets of over $200 million each. They failed to generate a profit.
"F1" comes in with a reported production budget of $250 million and a marketing budget of $100 million, which means the film is still far away from breaking even for Apple, especially when accounting for the split it will pay out to movie theater companies.
The film <a href="https://www.boxofficemojo.com/year/2025/?ref_=bo_yl_table_1">ranks </a>11th domestically for the year, earning $109.5 million, and 10th worldwide at $293.6 million. While the film may not stay there, a top 10 film of the year would put Apple's film unit on the map.
Read Also: <a href="https://www.benzinga.com/24/03/37558754/apples-1b-gamble-on-3-blockbusters-analyzing-box-office-results-streaming-impact-and-oscar-nominatio">Apple&#8217;s $1B Gamble On 3 Blockbusters &#8211; Box Office Results, Streaming Impact, And Oscar Nominations</a>
Why It's Important: While Apple films have not been profitable yet, they are an important part of the company's entertainment division, which includes the AppleTV+ streaming platform.
Apple could release the films as streaming exclusives. But the box office route helps eat the high costs of making the movie and allows it to campaign for major award nominations.
Prediction market <a href="https://kalshi.com/markets/kxoscarnompic/oscar-nominations-for-best-picture">Kalshi </a>currently lists a 22% chance that "F1" is nominated for Best Picture and a 12% chance that Pitt will be nominated for Best Actor for the film.
<iframe loading="lazy" src="https://kalshi.com/external-widgets/events/KXOSCARNOMPIC-26?color_scheme=light&#038;widget_size=medium&#038;variant=a&#038;ids=KXOSCARNOMPIC-26-SIN&#038;ids=KXOSCARNOMPIC-26-SEN&#038;ids=KXOSCARNOMPIC-26-WIC" width="488px" height="196px" style="border:0"></iframe>
Award nominations could help boost the prominence of "F1" and Apple's place in the film world. Apple was the first streaming company to ever win the Best Picture with "CODA" previously.
While Apple's stock price may not get a boost from "F1's" success at the box office, there is a good chance that its streaming platform could get a boost when the film is added to Apple TV+. Apple also has the chance to time the launch of <a href="https://www.benzinga.com/general/entertainment/24/07/40014040/apple-to-follow-netflix-disney-ad-supported-appletv-streaming-plan-could-launch-soon">its rumored ad-supported</a> streaming plan around the time that "F1" hits the platform. Apple has previously offered promotions like free preview weekends around major series releases.
Launching an ad-supported plan could be the next catalyst for AppleTV+ and the timing with "F1" hitting the platform could be a potential huge boost for Apple on the streaming front.
In the most recently <a href="https://www.benzinga.com/news/earnings/25/05/45152493/apple-reports-strong-q2-earnings-revenue-beat-eps-beat-installed-base-hits-all-time-high-across-all-segments-100-billion-buyback-and-more">reported second quarter,</a> Apple reported $68.7 billion in product revenue, $26.65 billion in services revenue and a quarterly total of $94.53 billion in revenue.
With an estimated 45 million paid streaming subscribers who pay around $10 per month, the $450 million per month isn't a ton to move the needle. Apple loses an <a href="https://variety.com/2025/digital/news/apple-tv-plus-streaming-losses-1-billion-per-year-1236344052/">estimated </a>$1 billion per year from its streaming platform.
Whether the debut of "F1" on the platform, along with an ad-supported plan, brings Apple TV+ closer to profitability this year remains to be seen.
Price Action: Apple stock is down 0.5% to $212.47 on Monday, versus a 52-week trading range of $169.21 to $260.09. Apple stock is down 12.8% year-to-date in 2025.  
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/entertainment/24/12/42750888/top-anticipated-2025-movies-for-big-screen-success-and-stocks-investors-should-watch">Top Anticipated 2025 Movies For Big Screen Success And Stocks Investors Should Watch</a></li>
</ul>
Image: Shutterstock

Entertainment

General

F1 Is Apple's Biggest Box-Office Win—So Why Is The Stock Stalling?

ATS shares are trading lower. The company announced that its CEO will step down at the end of August.

CLSK

CleanSpark shares are trading lower after the company released June 2025 Bitcoin mining and production updates.

GSAT

Globalstar shares are trading higher after the company announced it signed an agreement with SpaceX to provide satellite services for the launch of Falcon 9.

Dividends

Press Releases

Truist declares common and preferred stock dividends

Truist provides schedule for 2026 earnings conference calls

Truist to speak at the Morgan Stanley US Financials Conference

AI Revolution Hits Atlanta: Exclusive Symposium to Equip Entrepreneurs for a New Business Era

Truist appoints Jonathan Pruzan to its board of directors

Truist strengthens commercial banking teams across Ohio and Western Pennsylvania

Truist names Charles Alston head of its new Nonprofit Hospitals, Higher Ed and Government banking team

Truist announces second-quarter 2025 earnings call details

Truist expands Commercial and Corporate Banking business with key hires and appointments

Truist announces planned capital deployment and stress capital buffer requirement following release of 2025 CCAR results

Comments

Truist Finl

Interés en corto

Truist Finl (NYSE:TFC) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL